Skip to main content
Premium Trial:

Request an Annual Quote

Peter Banks, Michael Smith

Premium
BioTek Instruments announced this week that it has hired Peter Banks as scientific director. Banks will manage BioTek's applications group, while also providing scientific leadership and direction in emerging trends, opportunities, and scientific discovery across its global business platforms.
 
Before joining BioTek, Banks served as technology leader of bio-discovery with PerkinElmer Life and Analytical Sciences. From 2002 to 2005, Banks held a series of leadership roles with PerkinElmer, including R&D manager in Montreal and R&D portfolio leader for the life sciences business.
 

 
Michael Smith has joined the board of directors for Carestream Health, the company announced this week.
 
Until his retirement in 2005, Smith served as executive vice president and chief financial officer for Anthem, and its subsidiaries, Anthem Blue Cross and Blue Shield. Prior to that, he served as COO and CFO of American Health Network, a former Anthem subsidiary.
 
Smith was previously chairman, president, and CEO of Mayflower Group.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.